Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Geologica Closes Financing And Property Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InnovAge Holding Corp INNV

Healthcare Drug Manufacturers - Major
InnovAge Holding Corp. is a healthcare delivery platform. It is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The Company's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly (PACE... see more

Recent & Breaking News (NDAQ:INNV)

Innovus Pharmaceuticals to Release First Quarter 2017 Financial Results and Provide Corporate Update on Friday, May 12, 2017

Business Wire May 3, 2017

Innovus Pharma Launches ProstaGorx™ Product for Prostate Health Through its Beyond Human® Sales and Marketing Platform in the United States

Business Wire May 1, 2017

Innovus Pharmaceuticals Receives Patent for Its Sensum+® Product in Morocco

Business Wire April 12, 2017

Innovus Pharma Announces Receipt of Notification to Commercialize Zestra Glide® in the European Union

Business Wire April 5, 2017

Innovus Pharmaceuticals Announces Receipt of Notice of Intention to Grant Sensum+® European Patent

Business Wire March 27, 2017

Innovus Pharmaceuticals Announces the Cash Redemption of All Outstanding Convertible Notes

Business Wire March 22, 2017

Innovus Pharmaceuticals Announces $3.85 Million Public Offering

Business Wire March 16, 2017

Innovus Pharma Announces Receipt of Notification to Commercialize Sensum+® in the European Union

Business Wire March 8, 2017

Innovus Pharmaceuticals Reports Record Annual Revenues for the Full Year 2016 of $4.8 Million

Business Wire March 6, 2017

Innovus Pharma Announces Receipt of Notification to Commercialize Zestra® in the European Union

Business Wire March 2, 2017

Innovus Pharmaceuticals to Release Fourth Quarter and Full Year 2016 Financial Results and Provide Corporate Update on Monday, March 6, 2017

Business Wire February 28, 2017

Innovus Pharma Announces the Approval to Commercialize Zestra® in South Korea Through its Partner J&H Co. LTD

Business Wire February 3, 2017

Innovus Pharma Expands its Executive Management Team with the Addition of Randy Berholtz as its Executive Vice President, Corporate Development and General Counsel

Business Wire January 6, 2017

Powerful Marketing Platform and Strong Clinical Trials Results Boost Revenues for Innovus, Says CEO Bassam Damaj

Marketwired December 19, 2016

Innovus Pharma Strengthens its Respiratory Franchise with the In-Licensing of Lertal® Tablets, a Clinically Proven Supplement for the Relief of Allergic Rhinitis Symptoms from NTC for the United States and Canada

Business Wire December 19, 2016

Reimbursement of Innovus Pharmas Largest Selling Product Vesele -- SECFilings.com

Marketwired December 9, 2016

Innovus Pharma Launches its Clinically Proven UriVarx™ Product for Bladder Health Through its Beyond Human® Sales and Marketing Platform in the United States

Business Wire December 1, 2016

Innovus Pharma Signs $2 Million a Year Exclusive License and Distribution Agreement with J&H Co. LTD for Zestra® for Female Sexual Arousal in South Korea

Business Wire November 29, 2016

Innovus Pharma Launches Zestra® Multi-Dose Form for Female Sexual Arousal in the U.S.

Business Wire November 21, 2016

Innovus Pharma (INNV) Continues to Execute with Record Q3 '16 Revenue -- SECFilings.com

Marketwired November 18, 2016